Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer.

Faber MT, Jensen A, Frederiksen K, Glud E, Høgdall E, Høgdall C, Blaakaer J, Kjaer SK.

Cancer Causes Control. 2013 Dec;24(12):2197-206. doi: 10.1007/s10552-013-0296-8.

PMID:
24077761
2.

Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.

Huusom LD, Frederiksen K, Høgdall EV, Glud E, Christensen L, Høgdall CK, Blaakaer J, Kjaer SK.

Cancer Causes Control. 2006 Aug;17(6):821-9.

PMID:
16783610
3.

Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer.

Kjaerbye-Thygesen A, Frederiksen K, Høgdall EV, Glud E, Christensen L, Høgdall CK, Blaakaer J, Kjaer SK.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):798-803.

4.

P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study.

Høgdall EV, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK.

Gynecol Oncol. 2006 Jan;100(1):76-82. Epub 2005 Sep 23.

PMID:
16183105
5.

Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.

Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J.

Arch Intern Med. 2004 Nov 8;164(20):2253-9.

PMID:
15534163
6.

The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.

Begum FD, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, Glud E, Høyer-Hansen G, Ring-Larsen H, Høgdall EV.

Anticancer Res. 2004 May-Jun;24(3b):1981-5.

7.

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.

Høgdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Høgdall CK.

Cancer. 2004 Jun 1;100(11):2387-95.

8.

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.

Høgdall EV, Kjaer SK, Glud E, Christensen L, Blaakaer J, Vuust J, Bock JE, Norgaard-Pedersen B, Hogdall CK.

Anticancer Res. 2003 Jul-Aug;23(4):3397-404.

PMID:
12926080
9.

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK.

Oncol Rep. 2003 Sep-Oct;10(5):1535-8.

PMID:
12883737
10.

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK.

Cancer. 2003 Jul 1;98(1):66-73.

11.

K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study.

Høgdall EV, Høgdall CK, Blaakaer J, Christensen L, Bock JE, Vuust J, Glud E, Kjaer SK; Danish "Malova" Ovarian Cancer Study.

Gynecol Oncol. 2003 Apr;89(1):31-6.

PMID:
12694651
12.

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.

Høgdall EV, Høgdall CK, Blaakaer J, Heegaard NH, Glud E, Christensen L, Bock JE, Nørgaard-Pedersen B, Wiik A, Kjaer SK.

APMIS. 2002 Aug;110(7-8):545-53.

PMID:
12390412
13.

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.

Høgdall EV, Høgdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, Vuust J, Nørgaard-Pedersen B, Kjaer SK.

Anticancer Res. 2002 May-Jun;22(3):1859-64.

PMID:
12168882
14.

Fertility drugs and ovarian cancer.

Glud E, Kjaer SK, Troisi R, Brinton LA.

Epidemiol Rev. 1998;20(2):237-57. Review. No abstract available.

PMID:
9919441
15.

[P-pills and risk of breast cancer. A review of studies published 1970-1990].

Glud E, Ewertz M.

Ugeskr Laeger. 1992 Jan 27;154(5):260-6. Review. Danish.

PMID:
1736458
16.

The role of the body-image in psychotherapy with the physically handicapped.

CATH SH, GLUD E, BLANE HT.

Psychoanal Rev. 1957 Jan;44(1):34-40. No abstract available.

PMID:
13408380
17.

Body-image changes in patients with respiratory poliomyelitis; preliminary report.

GLUD E, BLANE HT.

Nerv Child. 1956 Jan;11(2):25-39. No abstract available.

PMID:
13348791
18.

The treatment of alcoholic patients in Denmark with antabuse with suggestions for its trial in the United States.

GLUD E.

Q J Stud Alcohol. 1949 Sep;10(2):185-97. No abstract available.

PMID:
18134706

Supplemental Content

Support Center